NCT06370013Available不适用
An Open Label, Multicenter Rollover Study for Continued Characterization of Safety and Tolerability of TT-00420 (Tinengotinib) Tablet Monotherapy in Adult Patients With Advanced Solid Tumors
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- Available
- 试验地点
- 5
研究概览
简要总结
This study is an open-label, multicenter study for Continued Characterization of Safety and Tolerability of TT-00420 (tinengotinib) Tablet Monotherapy in Adult Patients with Advanced Solid Tumors
详细描述
This is a Rollover study. Only subjects who continue to receive clinical benefit from continuation of tinengotinib monotherapy and are tolerating tinengotinib at the time of enrollment are eligible to participate on this study. Subjects on this rollover study may continue to receive tinengotinib at the dose that they were previously receiving on the TransThera parent study and may continue for as long as the subject continues to benefit from treatment.
研究设计
- 研究类型
- Expanded Access
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject is currently enrolled in a pre-defined TransThera-sponsored parent study and is receiving tinengotinib as a single agent.
- •Subject is currently deriving clinical benefit from the study treatment, as determined by the investigator.
排除标准
- •Subject has been permanently discontinued from tinengotinib in the parent protocol for any reason other than enrollment in the Rollover study
- •Subject does not meet the criteria specified in the parent protocol for continued treatment on study.
研究者
研究点 (5)
Loading locations...
相似试验
终止
3 期
A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)Alzheimer DiseaseNCT04374253Hoffmann-La Roche1,382
已完成
2 期
Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)Amyotrophic Lateral SclerosisNCT00931944Knopp Biosciences74
已完成
3 期
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic SeizuresPartial-Onset or Primary Generalized Tonic-Clonic SeizuresNCT02849626Eisai Inc.180
招募中
2 期
Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal HemoglobinuriaNCT06745622Haisco Pharmaceutical Group Co., Ltd.47
撤回
2 期
Study Evaluating Patients With CystinuriaCystinuriaNCT04137978Advicenne Pharma